Yongmei Liu

Anhui Medical University — China

Medicine · Health Sciences

11h-index843citations39works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(14), Lung Cancer Research Studies(11), Lung Cancer Diagnosis and Treatment(6), Colorectal Cancer Treatments and Studies(5), Advanced Radiotherapy Techniques(3)

Publications39 total

Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study
Translational Lung Cancer Research·2025Open Access
Combining immune checkpoint inhibitors with thoracic radiotherapy enhances outcomes in advanced non-small-cell lung cancer: a real-world study
Frontiers in Oncology·2025· 1 citedOpen Access
Molecular testing, treatment patterns, and outcomes in EGFR-mutated non-small cell lung cancer: the PISCES study
Future Oncology·2025· 1 cited
Autoantibody profiling using microarray identifies biomarkers associated with chemoimmunotherapy efficacy and immune-related adverse events in lung cancer patients
Clinical and Experimental Medicine·2025· 2 citedOpen Access
ZBTB16 exerts anti-angiogenic effects in rheumatoid arthritis by regulating HIF-1α pathway
Allergologia et Immunopathologia·2025· 1 citedOpen Access
Author response for "Efficient advanced reduction with cobalt phthalocyanine-decorated N-doped mesoporous carbon"
2025
Ship Kelvin Wake Velocity Inversion Method Based on KelvinPointNet in Polarization Images
IEEE Transactions on Geoscience and Remote Sensing·2025
Efficient advanced reduction with cobalt phthalocyanine-decorated N-doped mesoporous carbon
Materials Advances·2025Open Access
Author response for "Ship Kelvin Wake Velocity Inversion Method Based on KelvinPointNet in Polarization Images"
2024
DNA Methylation Age Mediates Effect of Metabolic Profile on Cardiovascular and General Aging
Circulation Research·2024· 14 cited
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
Med·2024· 39 cited
Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health
Journal of Virology·2023· 25 citedOpen Access
Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of GEC255, a novel KRAS<sup>G12C</sup> inhibitor, in advanced solid tumors.
Journal of Clinical Oncology·2023· 9 cited
COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China
Frontiers in Public Health·2023· 3 citedOpen Access
Abstract CT219: Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study
Cancer Research·2023· 2 cited
Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study
Cancer Science·2023· 12 citedOpen Access
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study
Journal of Cancer Research and Clinical Oncology·2021· 15 citedOpen Access
Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study.
Journal of Clinical Oncology·2021
Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium risk hypertension: study protocol for a randomized double-blind controlled trial
Research Square (Research Square)·2021Open Access
End to end intussusception anastomosis decreases the risk of anastomotic leakage after neoadjvant chemoradiation and McKeown oesophagectomy
Radiotherapy and Oncology·2021· 8 cited
page 1 of 2Next →

Frequent Co-authors

Meijuan Huang(16), Youling Gong(13), You Lü(11), Jiang Zhu(9), Lin Zhou(9), Yanying Li(8), Yong Xu(7), Yongsheng Wang(7), Jianxin Xue(6), Zhenyu Ding(6), You Lu(6), Xiaojuan Zhou(6), Feng Peng(6), Bingwen Zou(5), Yan Zhang(5), Feng Peng(5), Xiaojuan Zhou(4), Lei Deng(4), Jiang Zhu(4), Youling Gong(4)